Showing results (21-30 of 43) with videos related to

Sort By:
Pageof 5
Cellular and Molecular Life Sciences : CMLS|July 21, 2022
Moxifloxacin rescues SMA phenotypes in patient-derived cells and animal modelCamille Januel, Giovanna Menduti, Kamel Mamchaoui, et al.
Molecular Therapy. Nucleic Acids|September 30, 2021
Musashi-2 contributes to myotonic dystrophy muscle dysfunction by promoting excessive autophagy through <i>miR-7</i> biogenesis repressionMaria Sabater-Arcis, Ariadna Bargiela, Nerea Moreno, et al.
Scientific Reports|January 10, 2023
Quantitative magnetic resonance imaging assessment of muscle composition in myotonic dystrophy miceAriadna Bargiela, Amadeo Ten-Esteve, Luis Martí-Bonmatí, et al.
Disease Models & Mechanisms|June 21, 2015
Increased autophagy and apoptosis contribute to muscle atrophy in a myotonic dystrophy type 1 Drosophila modelAriadna Bargiela, Estefanía Cerro-Herreros, Juan M Fernandez-Costa, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 23, 2019
Increased Muscleblind levels by chloroquine treatment improve myotonic dystrophy type 1 phenotypes in in vitro and in vivo modelsAriadna Bargiela, Maria Sabater-Arcis, Jorge Espinosa-Espinosa, et al.
Biological Research|May 17, 2024
Therapeutic potential of oleic acid supplementation in myotonic dystrophy muscle cell modelsNerea Moreno, Maria Sabater-Arcis, Teresa Sevilla, et al.
Disease Models & Mechanisms|November 3, 2012
Muscleblind, BSF and TBPH are mislocalized in the muscle sarcomere of a Drosophila myotonic dystrophy modelBeatriz Llamusi, Ariadna Bargiela, Juan M Fernandez-Costa, et al.
Drug Discovery Today|August 7, 2017
Myotonic dystrophy: candidate small molecule therapeuticsPiotr Konieczny, Estela Selma-Soriano, Anna S Rapisarda, et al.
International Journal of Molecular Sciences|May 27, 2026
Oleic Acid Levels in HSA<sup>LR</sup> Mouse Model of Myotonic Dystrophy Type 1Dulce Peris-Moreno, Maria Sabater-Arcis, Nerea Moreno, et al.
Pageof 5